Fennell George's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Feb 9, 2024
- Accession no.
- 0000874716-24-000017
- Filed
- Feb 9, 2024
- Trade date
- Feb 8, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 2 derivative transactions. Open-market sales total $4.70M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fennell GeorgeCIK 0001521861 | Officer (SVP, Chief Revenue Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | MOption exerciseAcquired | +1,612 | $62.00 | +$99,944 | 6,712 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseAcquired | +8,198 | $62.00 | +$508,276 | 14,910 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −1,209 | $572.14F1 | −$691,717.26 | 13,701 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −2,279 | $572.78F2 | −$1,305,365.62 | 11,422 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −1,125 | $573.98F3 | −$645,727.5 | 10,297 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −3,173 | $575.02F4 | −$1,824,538.46 | 7,124 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −412 | $575.80F5 | −$237,229.6 | 6,712 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −1,612 | $0.00 | $0 | 0 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −8,198 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average price of the shares sold ranging from a low of $571.50 to a high of $572.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents the weighted average price of the shares sold ranging from a low of $572.525 to a high of $573.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of the shares sold ranging from a low of $573.58 to a high of $574.56 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold ranging from a low of $574.625 to a high of $575.39 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of the shares sold ranging from a low of $575.78 to a high of $575.845 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Referenced by the price of 1 transaction in Table I.